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Abstract: 
Background & Aims: Helicobacter pylori infection induces an inflammatory response, 
which can contribute to gastric tumorigenesis. Induction of cyclooxygenase-2 (COX-2) 
results in production of prostaglandin E2 (PGE2), which mediates inflammation. We 
investigated the role of bacterial infection and the PGE2 pathway in gastric tumorigenesis.  
 
Methods: We generated a germ-free (GF) colony of K19-Wnt1/C2mE mice (Gan mice), 
which develop gastric cancer, and examined tumor phenotypes, expression of cytokines and 
chemokines, and recruitment of macrophages. We also investigated PGE2 signaling through 
the receptor EP4 in Gan mice injected with specific inhibitors.  
 
Results: Gastric tumorigenesis was significantly suppressed in GF-Gan mice; reconstitution 
of commensal flora or infection with Helicobacter felis induced gastric tumor development. 
Macrophage infiltration was significantly suppressed in the stomachs of GF-Gan mice and 
EP4 inhibitor-treated Gan mice with decreased expressions of cytokines and chemokines. 
PGE2 signaling and bacterial infection or stimulation with lipopolysaccharide induced 
expression of the chemokine CCL2 (which attracts macrophage) in tumor stromal cells or 
cultured macrophages, respectively. CCL2 inhibition suppressed macrophage infiltration in 
tumors and depletion of macrophages from the Gan mouse tumors led to signs of tumor 
regression. Wnt signaling was suppressed in the tumors of GF-Gan and Gan mice given 
injections of tumor necrosis factor (TNF)- neutralizing antibody.  
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Conclusions: Bacterial infection and PGE2 signaling are required for gastric tumorigenesis in 
mice, by the cooperative upregulation of CCL2, which recruits macrophage recruitment to 
gastric tumors. Macrophage-derived TNF- promotes Wnt signaling in epithelial cells, which 
contributes to gastric tumorigenesis. 
 
KEY WORDS: LPS; stomach cancer, tumor progression, H. pylori 
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Introduction 
Gastric cancer is the second most common cause of cancer-related death in the world, 
and Helicobacter pylori infection is closely associated with gastric cancer development1.  
Infections are estimated to be related to 15% of malignant cancer development, and 
infection-associated inflammation is a critical component of cancer development2.  For 
example, an inflammatory response promotes tumor cell proliferation, metastasis and survival, 
whereas it suppresses anti-tumor immune responses2-4.  Moreover, the genetic polymorphisms 
in genes encoding inflammatory cytokines influence gastric tumorigenesis5.  These results 
suggest that an inflammatory cytokine network induced by H. pylori infection plays a key role 
in gastric tumorigenesis.   
Cycooxygenase-2 (COX-2) is an inducible enzyme for prostaglandin biosynthesis, 
which plays an important role in both inflammation and tumorigenesis6,7.  Mouse model 
studies have indicated that induction of the COX-2/prostaglandin E2 (PGE2) pathway 
accelerates intestinal tumorigenesis through the induction of angiogenesis and suppression of 
apoptosis8,9.  Among four PGE2 receptors, EP1-EP4, EP4 receptor signaling has been shown 
to play an important role in intestinal tumorigenesis through the activation of epidermal 
growth factor receptor10.  The expression of COX-2 is also found in more than 70% of gastric 
cancers11, which is suppressed by the eradication of H. pylori12, suggesting COX-2 induction 
by infection in the gastric mucosa.  Transgenic mice expressing COX-2 and a PGE2 
converting enzyme, mPGES-1, in the stomach develop hyperplasia with macrophage 
infiltration, indicating the role of PGE2 in macrophage recruitment13.  Tumor-associated 
macrophages (TAMs) play an important role in tumorigenesis through the enhancement of 
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angiogenesis, migration, and remodeling14.  Moreover, the simultaneous activation of Wnt 
and the PGE2 pathways in the mouse stomach causes dysplastic tumor development15.  
Accordingly, it is possible that PGE2-dependent macrophage recruitment is one of the 
important mechanisms underlying the H. pylori infection-associated inflammation in gastric 
tumorigenesis.  However, the relationship between bacterial infection and PGE2 signaling in 
gastric tumorigenesis remains unclear. 
Commensal bacteria constitutively stimulate the intestinal mucosa, inducing cytokines 
and chemokines at a basal level, which is important for homeostasis of the intestinal mucosa16.  
The present study shows that indigenous bacteria constitutively stimulate the gastric mucosa, 
which is required for tumorigenesis in the Wnt-activated and PGE2-induced gastric mucosa.  
Bacterial colonization and PGE2 signaling through EP4 receptor cooperatively induced the 
expression of CCL2, which was a major pathway for macrophage recruitment in the gastric 
mucosa.  Furthermore, depletion of macrophages caused regressive signs of tumors.  These 
results indicate that bacterial infection and PGE2 signaling cooperatively recruit macrophages 
to the gastric mucosa, which promotes gastric cancer development. 
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Materials and Methods 
Animal experiments 
The construction of K19-Wnt1 [Tg(Krt19-Wnt1)2Maos], K19-C2mE 
[Tg(Krt19-Ptgs2,Krt19-Ptges)8Tko], and K19-Wnt1/C2mE (Gan for Gastric neoplasia) 
[Tg(Krt19-Wnt1)2Maos/Tg(Krt19-Ptgs2,Krt19-Ptges)8Tko] transgenic mice was described 
previously (Supplementary Table 1)13,15  All mice used in the present study were backcrossed 
to C57BL/6 mice more than 12 times (>N12).  Germfree mouse colonies of all genotypes and 
wild-type mice were established by Caesarean derivation at the Central Institute for 
Experimental Animals (CIEA, Japan), and the mice were raised in germfree isolators under 
germfree conditions.  During the experiments, germfree conditions were monitored by 
cultures of feces, bedding, and swabs in thioglycollate medium or potato dextrose broth every 
2-5 weeks (Supplementary Table 2).  SPF-raised mice were maintained in the SPF facility at 
Kanazawa University.  The excluded pathogens in the SPF facility are listed in Supplementary 
Table 3.  Mice were euthanized and examined at 30 and 55 weeks of age (n=4-6), and all 
experimental groups consisted of both female and male mice.  Half of the glandular stomach 
was used for the histological analysis, and the other half was used for RNA and protein sample 
preparation.  Six germfree Gan mice were moved to the SPF facility at 7 weeks of age, 
reconstituted with commensal flora by co-housing with SPF mice and adding dirty bedding 
from other cages, and examined at 30 weeks of age.  Helicobacter felis (ATCC 49179) were 
inoculated at 108/mouse p.o. to germfree Gan mice at 30 weeks of age (n=3), and gastric 
phenotypes were examined at 55 weeks of age.  The time course and experimental conditions 
for each group are shown in Supplementary Figure 1.  All animal experiments were carried 
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out according to the protocol approved by the Committee on Animal Experimentation of 
Kanazawa University. 
Gastric pH Measurement 
Gastric pH was measured as described17.  Briefly, mice were fasted overnight before 
necropsy.  Sterile water (1.5 ml) was injected into the stomach, the stomach was massaged 
gently, and the pH of the gastric contents was measured using a pH meter.   
Drug treatment experiments 
The EP4 receptor inhibitor, RQ-00015986/CJ-4279418 was provided from RaQualia 
Pharma Inc. (Taketoyo, Japan).  Gan mice were treated with RQ-00015986 at 100 mg/kg/day 
p.o. from 27 or 52 weeks of age for 3 weeks (n=4-5).  For inhibition of TNF- or CCL2, Gan 
mice were injected with a neutralizing antibody against TNF- (AB-410-NA, R&D Systems, 
Minneapolis, MN) at 8 mg/kg/day i.p. for 6 days (n=3) or an antibody against CCL2 
(AF-479-NA, R&D Systems) at 1 mg/kg/day i.p. for 3 days (n=3), respectively.  Macrophages 
were depleted in vivo by injection of 200 l of clodronate (dichloromethylene 
bisphosphonate)-loaded liposomes i.v. every 3 days for 2 weeks as previously described19.  
Clodronate was a gift from Roche Diagnostics GmbH (Mannheim, Germany), and was 
encapsulated in liposomes as described previously20. 
Histology and immunohistochemistry 
Stomach tissues were fixed in 4% paraformaldehyde, paraffin-embedded and sectioned 
at 4 m-thickness.  These sections were stained with H&E or processed for immunostaining.  
Tissues were also embedded in OCT compound, frozen in liquid nitrogen, and sectioned at 10 
m-thickness.  The frozen sections were used for CCL2 immunostaining.  Antibodies against 
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the proton pump (MBL, Nagoya, Japan), F4/80 (Serotec, Oxford, UK), -catenin (Sigma, St. 
Louis, MO), CCL2 (Hycult Biotech, Uden, The Netherlands), EP4 (MBL), CD44 (Millipore, 
Billerica, MA), EphB3 (Bioworld Technology, St. Louis Park, MN) and Ki-67 (Dako, 
Carpinteria, CA) were used as the primary antibodies.  Staining signals were visualized using 
the Vectastain Elite Kit (Vector Laboratories, Burlingame, CA).  For fluorescence 
immunostaining, Alexa Fluor 594 or Alexa Fluor 488 antibody (Molecular Probes, Eugene, 
OR) was used as the secondary antibody.  Apoptosis was examined using the ApopTag 
Apoptosis Detection Kit (Millipore).  The mean index for F4/80 (macrophage), proton pump 
(parietal cell), Ki-67, or apoptosis was calculated by counting labeled cells per microscopic 
field (200) in 5 fields. 
Scoring tumor volume and preneoplastic lesions 
The mucosal thickness (tumor height) of the gastric tumors of Gan mice and the normal 
stomach of wild-type mice was measured from histology sections.  The mucosal thickness 
relative to that of wild-type mice was calculated.  The number of preneoplastic lesions in the 
whole glandular stomach of K19-Wnt1 mice was counted under a dissection microscope after 
staining with 0.05% toluidine blue.  The histological characteristics of gastric tumors and 
preneoplastic lesions were described previously15.  The histology of these lesions was 
confirmed after scoring. 
Cell culture experiments 
The RAW264 macrophage cells (RIKEN BioResource Center, Japan) were treated with 
lipopolysaccharide (LPS) (Sigma) for 24 h at 1, 10, 50, 100, 1,000, or 10,000 pg/ml with or 
without treatment with a COX-2 inhibitor, celecoxib, or RQ00015986 at 10 M, and the 
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expression levels of CCL2 and cytokines were examined.  Celecoxib was provided by Pfizer 
(New York, NY).  For the primary culture of gastric epithelial cells, the glandular stomach of 
K19-Wnt1 mice was treated with 0.1% collagenase followed by trypsin, and epithelial cells 
were cultured in matrigel (BD Pharmingen, Franklin Lakes, NJ) with EGF (-) primary culture 
medium13.  The primary cultured cells were treated with RQ00015986 at 10 M for 6 days, 
and organoid structures consisting of epithelial cells larger than 0.2 mm in diameter were 
counted. 
Immunoblotting analysis 
The tissues were homogenized and sonicated in lysis buffer.  Thereafter, the specimens 
were centrifuged at 20,000  g, and 10 g of the supernatant protein sample was separated in 
a 10% SDS-polyacrylamide gel.  An antibody against unphosphorylated active -catenin 
(Millipore) was used as the primary antibody.  Anti--actin (Sigma) was used as the internal 
control.  The ECL detection system (GE Healthcare, Buckinghamshire, UK) was used to 
detect the signals. 
Real-time reverse transcription-polymerase chain reaction (RT-PCR) 
Tumor stroma and epithelial cell samples were separately collected from frozen sections 
using Laser Microdissection (Leica, Wetzlar, Germany).  Total RNA was extracted from the 
tissues or microdissected samples using ISOGEN (Nippon Gene, Tokyo, Japan), reverse 
transcribed with PrimeScript RT reagent Kit (Takara, Tokyo, Japan), and PCR-amplified by 
Stratagene Mx300P (Agilent Technologies, Santa Clara, CA) using SYBR Premix ExTaqII 
(Takara).  Primers for the real-time RT-PCR were purchased (Takara), and the primer 
sequences are shown in Supplementary Table 4. 
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Statistical analysis 
The data were analyzed using the unpaired t-test and are presented as the means  
standard deviation (s.d.).  A value of P < 0.05 was considered to be statistically significant 
(Asterisks, P < 0.05). 
12 
Results 
Constitutive stimulation of gastric mucosa by indigenous bacteria 
To determine whether indigenous bacteria in the stomach stimulate the gastric mucosa, 
we examined the expression of cytokines and chemokines in the glandular stomach of 
germfree (GF) wild-type mice and control SPF mice by real-time RT-PCR (Figure 1A).  
Importantly, the expression levels of TNF-, IL-1, KC and MIP-2 decreased significantly in 
the GF mouse stomach compared to the SPF mice, while IL-6 expression slightly increased.  
These results indicate that commensal bacteria constitutively stimulate the gastric mucosa to 
induce inflammatory cytokines and chemokines at a basal level.   
K19-Wnt1/C2mE gastric tumor model mice (Gan mice for Gastric neoplasia) were 
previously constructed by crossing K19-Wnt1 and K19-C2mE mice (Supplementary Table 
1)13,15.  We examined the number of parietal cells by immunostaining and measured 
intragastric pH in these models, because bacterial growth is affected by intragastric acidity.  
The mean parietal cell index was similar in all strains, and the intragastric pH was around 3.5 
(Figure 1B-D).  However, in the dysplastic tumors of Gan mice, the number of parietal cells 
decreased significantly, and intragastric pH increased at 50-55 weeks of age.  These results 
indicate that gastric acidity is not changed in Gan mice at early stages of disease compared to 
other models until large tumors develop at the later stages. 
Suppression of gastric tumorigenesis in germfree mice 
Gan mice raised in an SPF facility (SPF-Gan) developed large gastric tumors by 55 
weeks of age (Figure 2A and B), and the mean tumor height increased to about 1.5-fold when 
compared to that at 30 weeks of age.  In contrast, gastric tumorigenesis was significantly 
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suppressed in the germfree Gan (GF-Gan) mice, and the mean mucosal thickness of GF-Gan 
mice was less than 40% of the age-matched SPF-Gan mice (Figure 2A and B, Supplementary 
Figure 2).  Approximately 40% of the SPF-Gan mice showed a moribund phenotype and thus 
were euthanized by 60 weeks of age, whereas all GF-Gan mice survived by 55 weeks of age 
(Figure 2C).  Importantly, reconstitution of commensal bacteria in GF-Gan mice resulted in 
development of gastric tumors that were significantly larger than those of GF-Gan mice 
(Figure 2A, Supplementary Figure 2), and treatment of SPF-Gan mice with antibiotics 
significantly suppressed gastric tumor growth (Supplementary Figure 3).  These results 
indicate that colonization of indigenous bacteria is required for gastric tumor development.   
Moreover, infection with Helicobacter felis, separate species of Helicobacter pylori, in 
the GF-Gan mouse stomach at 30 weeks of age (GF->H. felis mice) induced the development 
of gastric tumors by 55 weeks of age (Figure 2A and B).  The infection of H. felis in gastric 
glands was confirmed by microscopy of histology sections (Supplementary Figure 4).  These 
results also indicate the role of infection in gastric tumorigenesis.   
Apoptotic cells were found only on the mucosal surface of gastric tumors (Figure 2D), 
and the mean apoptosis index was 42.4% and 40.0% on the mucosal surface in SPF-Gan and 
GF-Gan mice, respectively.  On the other hand, the number of Ki-67-labeled proliferating 
cells was significantly lower in the GF-Gan mouse stomach (Figure 2E and F), suggesting that 
bacterial colonization contributes to the tumor cell proliferation.   
Suppression of gastric tumorigenesis by inhibition of the PGE2 receptor, EP4 
There are four PGE2 receptors, EP1-EP4, and the expression level of EP4 was increased 
significantly in Gan mouse tumors21.  SPF-Gan mice were thus treated with a specific EP4 
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inhibitor, RQ-00015986, for 3 weeks from 52 weeks of age (Supplementary Figure 1).  
Notably, gastric tumors regressed significantly following inhibition of EP4, and the mean 
tumor size decreased to 23% of that of the age-matched SPF-Gan mice (Figure 2A and B).  
Moreover, treatment of SPF-Gan mice with an EP4 inhibitor during the early stage of 
tumorigenesis from 27 weeks of age also suppressed tumor development significantly.  These 
results indicate that EP4 signaling plays an important role in gastric tumorigenesis.   
Bacterial infection and EP4 signaling for inflammatory responses 
Submucosal lymphocyte infiltration was found in the SPF-Gan and GF->H. felis mouse 
tumors but not in GF-Gan and EP4 inhibitor-treated Gan (EP4i-Gan) mice (Figure 3A), 
suggesting that both bacterial infection or colonization and EP4 signaling are required for 
inflammatory responses.  Moreover, the expression level of proinflammatory cytokines, 
TNF-, IL-1, and IL-6, and chemokines, KC and MIP-2, were significantly elevated in the 
SPF-Gan and GF->H. felis gastric tumors (Figure 3B), indicating inflammatory responses in 
the stomachs of these mice.  In contrast, the expression of these cytokines and chemokines 
was not induced in the GF-Gan and EP4i-Gan mouse stomachs.  The transgenic expression of 
COX-2 (Ptgs2) in the stomach was confirmed in all mouse groups except the wild-type mice, 
indicating that the PGE2 level was elevated in all groups of Gan mice.  These results indicate 
that both infection and EP4 signaling are required for inflammatory responses in the stomach. 
The expression of proinflammatory cytokines was predominantly detected in stromal 
cells when compared with tumor epithelial cells in SPF-Gan tumors (Figure 3C), suggesting 
that stromal macrophages were the major source of these cytokines.  We thus examined 
macrophage infiltration by immunostaining.  As expected, numerous macrophages were 
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found in the SPF-Gan and GF->H. felis Gan mouse tumors, while macrophage infiltration 
was suppressed in the GF-Gan and EP4i-Gan mice (Figure 3D).  The number of macrophages 
in the GF-Gan and EP4i-Gan mouse stomachs decreased significantly to 11% and 33% of the 
SPF-Gan mouse level, respectively (Figure 3E).  These results suggest that cooperation of 
bacterial infection or colonization with EP4 signaling contributes to macrophage recruitment 
to the gastric mucosa. 
To examine the role of macrophages in gastric tumorigenesis, SPF-Gan mice were 
treated with clodronate liposomes to deplete macrophages in vivo.  Macrophage-depleted 
areas were found by immunostaining in the clodronate liposome-injected Gan mouse tumors 
(Figure 3F).  In the macrophage-depleted area, tumors showed regressive signs with atrophic 
changes of tumor cells or peel-off of tumor epithelial cells from the mucosal surface, 
suggesting that macrophages are important for the maintenance or survival of tumor epithelial 
cells. 
Induction of CCL2 by bacterial infection and EP4 signaling 
The expression level of macrophage-tropic chemokines was examined in the 
SPF-K19-C2mE and GF-K19-C2mE mouse stomach.  The PGE2 pathway but not Wnt 
signaling is activated in the glandular stomach of K19-C2mE mice (Supplementary Table 1).  
Importantly, expression of CCL2 and CCL8 increased significantly in the SPF-K19-C2mE 
mouse stomach compared to that in the wild-type mice (Figure 4A).  In contrast, expression of 
CCL2 and CCL8 was not induced in the GF-K19-C2mE mouse stomach.  Induction of CCL2 
and CCL8 expression was also found in gastric tumors of SPF-Gan mice but not in GF-Gan 
mice (Figure 4B).  These results suggest that PGE2 signaling and bacterial colonization 
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cooperatively induce expression of CCL2 and CCL8 in the gastric mucosa.   
Because CCL2 is an important chemokine for macrophage infiltration in colon tumors22, 
we further examined CCL2 expression.  CCL2-expressing cells were detected by 
immunostaining in the stroma of SPF-Gan mouse tumors where macrophages were 
accumulated (Figure 4C), suggesting that macrophages express CCL2.  The stimulation of 
RAW264 macrophage cells with LPS induced the expression of CCL2 in a dose-dependent 
manner (Figure 4D).  A low concentration of LPS was used for further experiments to 
examine the effect of low counts of indigenous bacterial colonization in the stomach.  
Importantly, treatment of RAW264 macrophages with an EP4 inhibitor significantly 
suppressed LPS-induced CCL2 expression (Figure 4E), suggesting that both EP4 signaling 
and LPS stimulation are required for CCL2 induction in macrophages.   
To examine the role of CCL2 in macrophage recruitment in gastric tumors, SPF-Gan 
mice were treated with an anti-CCL2 neutralizing antibody.  Notably, inhibition of CCL2 
suppressed macrophage infiltration in tumors, although a few macrophages were still detected 
(Figure 4F), suggesting that CCL2 is a major chemokine that recruits macrophages to gastric 
tumors.  In the macrophage-depleted tumor areas caused by CCL2 inhibition, tumors showed 
regressive signs, which was similar to the observations in the clodronate liposome-treated 
Gan mice (Figure 3F). 
M2 type polarization of macrophages in gastric tumors 
TAMs play a pivotal role in tumor development14.  Macrophage activation is classified 
as “classically” activated (M1) or “alternatively” activated (M2) type, and TAMs generally 
express characteristics of M2-polarized macrophages23.  Interestingly, the expression of M2 
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macrophage markers, Ym1, Ym2, Arg1, and TGF-, increased significantly in both the 
SPF-K19-C2mE stomach and SPF-Gan tumors (Supplementary Figure 5A).  Consistently, 
expression of an M2 marker, mannose receptor, was detected by immunohistochemistry in the 
SPF-Gan mouse tumors (Supplementary Figure 5B).  It has been reported that CD4+ T cells 
regulate the M2 properties of macrophages24.  CD4+ T cells infiltrated into the SPF-Gan 
mouse tumors (Supplementary Figure 5C).  However, M2 macrophages were also found in 
SPF-Rag2 -/- K19-C2mE mouse stomachs (Supplementary Figure 5D), suggesting that 
macrophages in the PGE2-induced inflammation can be polarized to the M2 type in the 
absence of T cells.   
EP4 signaling on macrophages and epithelial cells 
Expression of the EP4 receptor was detected by immunostaining in both tumor 
epithelial cells and stromal cells of SPF-Gan mice, whereas it was rarely detected in the 
GF-Gan or wild-type mouse stomach (Figure 5A).  Induction of EP4 in SPF-Gan tumors was 
confirmed by real-time RT-PCR (Figure 5B).  When RAW264 macrophages were stimulated 
with LPS, expression of COX-2 and mPGES-1, as well as proinflammatory cytokines, was 
elevated (Figure 5C).  Importantly, treatment of LPS-stimulated macrophages with an EP4 
inhibitor or celecoxib suppressed the induction of COX-2, IL-1 and IL-6.  Moreover, 
inhibition of EP4 suppressed proliferation of the primary cultured gastric epithelial cells in 
matrigel (Figure 5D).  These results suggest that EP4 signaling is also important for 
macrophage activation and epithelial cell proliferation. 
Wnt promotion by bacterial infection and TNF- stimulation 
Expression of Wnt-target genes, CD44 and EphB3, was significantly downregulated in 
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the GF-Gan and EP4i-Gan mouse stomachs (Figure 6A).  In the wild-type mouse stomach, 
expression of CD44 was found only in the neck of the gastric gland, whereas EphB3 was not 
detected (Figure 6B).  Notably, expression of CD44 and EphB3 was significantly induced in 
tumor epithelial cells of SPF-Gan mice, which was suppressed in GF-Gan mice. Consistently, 
the active -catenin level was decreased in the GF-K19-Wnt1 stomach and GF-Gan mouse 
gastric tumors compared to SPF mice (Figure 6C), indicating that Wnt signaling activity is 
suppressed under GF conditions.  We previously showed that macrophage-derived TNF- 
promotes Wnt signaling in gastric cancer cells25.  It is therefore possible that the decreased 
level of TNF- in the GF-Gan and EP4i-Gan mouse stomachs resulted in suppression of Wnt 
signaling.   
K19-Wnt1 mice develop preneoplastic lesions caused by promotion of Wnt signaling by 
macrophage-derived TNF-25 (Supplementary Table 1).  Importantly, the number of 
preneoplastic lesions decreased significantly in the GF-K19-Wnt1 mice compared to the 
SPF-K19-Wnt1 mice (Figure 6D), suggesting that bacterial colonization is important for 
macrophage recruitment, which triggers TNF--induced Wnt promotion.   
We next investigated whether TNF- promotes Wnt signaling in the gastric tumor 
tissues.  Treatment of the SPF-Gan mice with an anti-TNF- neutralizing antibody resulted in 
downregulation of TNF- in tumors, possibly caused by suppression of macrophage 
activation (Figure 6E).  Importantly, expression of EphB3, a Wnt-target gene, was also 
downregulated.  Consistently, the active -catenin level decreased in gastric tumors by TNF- 
inhibition (Figure 6F).  These results indicate that macrophage-derived TNF- enhances Wnt 
activity in gastric tumors, which may promote gastric tumorigenesis. 
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Discussion 
Accumulating evidence has indicated that infection-associated inflammation plays an 
important role in cancer development2.  Bacterial infection stimulates toll-like receptors 
(TLRs), which induces activation of the NF-B pathway.  The activation of NF-B causes 
tumor promotion through induction of growth factors and suppression of apoptosis26.  NF-B 
activation also induces COX-2 expression, which is followed by induction of the PGE2 
pathway.  The COX-2/PGE2 pathway plays a key role in intestinal tumorigenesis8,9.  These 
results indicate that infection plays a key role in the activation of the NF-B and PGE2 
pathways, which promotes tumorigenesis.  In the present study, we infected H. felis at 30 
weeks of age to examine the effect of infection in tumorigenesis, because we found a 
significant suppression of tumorigenesis in GF-Gan stomach at 30 weeks of age.  Importantly, 
H. felis infection to GF-Gan mice induced gastric tumor development by 55 weeks.  
Accordingly, the present study indicates that bacterial infection is still required for 
tumorigenesis even after the induction of the PGE2 pathway.   
It has been shown that PGE2 signaling through EP4 receptor is important for intestinal 
tumorigenesis through the activation of epidermal growth factor receptor10.  The current 
results also showed EP4 to play an important role in tumorigenesis.   Bacterial colonization 
and EP4 signaling cooperatively induce expression of macrophage-tropic chemokine, CCL2.  
It has been shown that CCL2 signaling is important for macrophage infiltration in colon 
cancers in the intestinal tumorigenesis22.  Accordingly, it is possible that expression of CCL2 
induced by bacterial colonization and EP4 signaling is important for macrophage recruitment 
in gastric tumorigenesis.   
20 
Intestinal commensal bacteria stimulate the TLRs in the mucosa, which is important for 
the proliferation of undifferentiated epithelial cells16.  Moreover, macrophages are an 
important niche component for the proliferation of intestinal progenitor cells in the tissue 
repair process27.  Accordingly, it is possible that the innate immune response to commensal 
bacteria is important for the proliferation of tumor epithelial cells through macrophage 
recruitment.  On the other hand, acquired immunity by T cells is essential for H. 
felis-associated gastric pathology28.  It is thus possible that T cells play a role in gastric 
tumorigenesis in H. felis-infected GF-Gan mice.  However, hyperplasia still developed, and 
the macrophages were polarized to M2, in the SPF-Rag2 -/- K19-C2mE mouse stomach29 
(Supplementary Figure 5D), suggesting that increased PGE2 levels and commensal flora can 
trigger these gastric phenotypes without T cell response.  
We previously showed that macrophage-derived TNF- promotes Wnt signaling 
activity in gastric cancer cells, which contributes to gastric tumorigenesis25.  Moreover, Wnt 
activation levels correlate with the incidence of intestinal tumorigenesis in Apc knockout 
mice30, and promotion of Wnt signaling activity may play an important role in malignant 
progression31.  In the present study, inhibition of TNF- resulted in a decrease in Wnt 
signaling activity in gastric tumors, confirming that TNF- functions as a Wnt promoting 
factor in vivo.  Notably, Wnt activity in the gastric tumors of GF-Gan mice was lower than that 
of SPF-Gan mice, which may have been caused by a decreased level of macrophage-derived 
TNF-.  Accordingly, it is possible that TNF--dependent Wnt promotion is one of the 
important mechanisms by which macrophages induce tumorigenesis, which is triggered by 
bacterial colonization and EP4 signaling. 
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The COX-2/PGE2 pathway has been shown to suppress the Th1 immune response in the 
H. pylori-infected stomach32.  Notably, NSAID treatment suppresses gastric carcinogenesis in 
the INS-GAS gastric tumor model mice.  However, NSAID treatment enhances gastritis in 
Helicobacter-infected INS-GAS mice, which may promote gastric tumorigenesis17.  These 
results suggest that the PGE2 pathway suppresses infection-associated carcinogenesis, which 
appears to be inconsistent with the present results.  However, the present results indicate that 
commensal flora with low bacterial counts can elicit gastritis when the mucosal PGE2 level is 
increased, and such commensal flora and PGE2-dependent inflammation is important for 
gastric tumorigenesis.  It is therefore possible that the role of PGE2 for immune responses and 
tumorigenesis varies according to the level of infection status, such as exogenous aggressive 
infection by Helicobacter or commensal colonization, although this remains to be 
investigated. 
In conclusion, bacterial infection or colonization, in cooperation with PGE2 signaling 
through the EP4 receptor, induces expression of CCL2, resulting in macrophage recruitment 
to gastric mucosa.  TNF- produced by macrophages promotes Wnt signaling in the tumor 
cells, which may promote gastric tumorigenesis.  Accordingly, the eradication and inhibition 
of the PGE2 pathway may be an effective strategy for preventing gastric cancer development. 
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Figure 1. Stimulation of normal gastric mucosa by indigenous bacteria.  (A) mRNA levels of 
cytokines and chemokines in the gastric mucosa of the germfree (GF)-wild-type mice (mean 
Log2 ratio to the SPF mouse level).  Asterisks, P < 0.05.  (B) Immunostaining for proton 
pumps (parietal cells) in the gastric mucosa of the indicated strains.  Scale bars, 100 m.  (C) 
The parietal cell index relative to the wild-type mouse level (mean  s.d.).  Asterisks, P < 0.05 
versus the wild-type level (WT).  Gan-NT: Gan non-tumor, Gan-DT: Gan dysplastic tumor.  
(D) Intra-gastric pH of the indicated mouse strains (mean  s.d.).  Asterisks, P < 0.05 versus 
the wild-type level (WT).   
 
Figure 2.  Suppression of gastric tumorigenesis in germfree (GF) Gan mice.  (A) The gastric 
mucosal thickness (tumor height) of SPF-Gan (SPF), GF-Gan (GF), Commensal 
flora-reconstituted GF-Gan (GF->SPF), H. felis-infected GF-Gan (GF->H. felis), and EP4 
inhibitor-treated-Gan (EP4i) mice at 30 and 55 weeks of age relative to wild-type mice (WT).  
(B) Representative macroscopic photographs of the stomach of the indicated group of Gan 
mice at 55 weeks of age.  Closed arrowheads indicate tumors, whereas the white arrowheads 
indicate suppressed tumorous lesions in the GF-Gan mouse.  (C) The survival rate of the 
SPF-Gan and GF-Gan mice.  All GF-Gan mice were used for experiments at 55 weeks of age.  
(D) Apoptosis analyses of SPF-Gan and GF-Gan mouse gastric tumors.  Arrows indicate 
apoptotic cells on the mucosal surface of tumors.  (E) Ki-67 immunostaining in the gastric 
tumors of SPF-Gan and GF-Gan mice.  Scale bars in (D) and (E), 100 m.  (F) Relative mean 
Ki-67 labeling index (mean  s.d.).  Asterisks, P < 0.05 versus SPF level.   
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Figure 3. Macrophage recruitment in the Gan mouse tumors.  (A) H&E staining of the 
SPF-Gan, GF-Gan, H. felis-infected GF-Gan (GF->H. felis), and EP4 inhibitor-treated Gan 
(EP4i-Gan) mouse stomachs.  Arrows indicate lymphocyte infiltration.  Scale bars, 100 m.  
(B) Relative mRNA levels of inflammatory cytokines, chemokines and COX-2 in wild-type 
mouse stomach (WT), and SPF-Gan (SPF), GF-Gan (GF), H. felis-infected GF-Gan (HF), 
and EP4i-Gan (EP4i) mouse gastric tumors (mean  s.d.).  Asterisks, P < 0.05 versus 
wild-type level.  (C) The mRNA level of inflammatory cytokines in the microdissected tumor 
epithelial cells (Ep) relative to the level in the tumor stroma (St).  Asterisks, P < 0.05.  (D) 
Immunostaining of F4/80 (green) with DAPI staining (blue) in gastric tumors of the indicated 
groups.  Arrowheads indicate F4/80-positive macrophages.  Scale bars, 100 m.  (E) The 
mean number of F4/80-positive macrophages per microscopic field (mean  s.d.).  Asterisks, 
P < 0.05 versus SPF level.  (F) Immunostaining of F4/80 (red) and -catenin (green) in gastric 
tumors of a control Gan mouse (left) and clodronate liposome-treated Gan mouse (center).  
H&E staining of serial section of a clodronate liposome-treated Gan mouse tumor (right).  
Scale bars, 100 m.  Arrowheads (left) indicate macrophages.  Arrowheads and arrows in 
(center and right) indicate the mucosal surface of the tumor and tumor cells, respectively, in 
the macrophage-depleted area. 
 
Figure 4. Chemokine induction by bacterial colonization and PGE2 signaling.  (A, B) The 
mRNA levels of the indicated chemokines in SPF-K19-C2mE (red) and GF-K19-C2mE (blue) 
gastric mucosa (A) and SPF-Gan (pink) and GF-Gan (purple) gastric tumors (B) relative to 
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that in the control SPF-wild-type mouse stomach (gray) (mean  s.d.).  The indigenous 
bacterial colonization (B.I.) and PGE2 transgenic status (PGE2) are indicated at the bottom.  
Asterisks, P < 0.05 versus wild-type level.  (C) Immunostaining of CCL2 (red, arrowheads) 
and -catenin (green) with DAPI staining (blue) in SPF-Gan gastric tumor.  Scale bar, 100m.  
(D) The mRNA levels of CCL2 in the LPS-stimulated RAW264 cells relative to that in the 
unstimulated control cells (mean  s.d.).  Asterisks, P < 0.05 versus control level.  (E) The 
mRNA levels of CCL2 in RAW264 cells with indicated treatment relative to the level in the 
unstimulated RAW264 cells (mean  s.d.).  Asterisks, P < 0.05.  (F) Immunostaining for 
F4/80 (red, arrowheads) and -catenin (green) with DAPI staining (blue) in tumors of control 
SPF-Gan (left) and CCL2 antibody-treated SPF-Gan mice (right).  Scale bars, 100m.  
Arrows in (right) indicate regressed tumors in the macrophage-depleted area. 
 
Figure 5. EP4 signaling on macrophages and epithelial cells.  (A) Immunostaining of EP4 in 
the normal gastric mucosa of wild-type mouse and gastric tumors of SPF- and GF-Gan mice.  
Arrowheads and arrows indicate stromal EP4 expression in the tumor epithelia and tumor 
stromal cells, respectively.  Scale bars, 100m.  (B) The mRNA levels of EP4 in gastric tumors 
of SPF-Gan and GF-Gan mice relative to the wild-type mouse level (mean  s.d.).  Asterisks, 
P < 0.05.  (C) The mRNA levels of inflammatory cytokines in the control or drug-treated 
RAW264 cells relative to the level of LPS-stimulated RAW264 cells (mean  s.d.).  Asterisks, 
P < 0.05 to the LPS-stimulated level.  (D) Representative photographs of organoid structures 
formed by the primary cultured gastric epithelial cells in matrigel with EP4 inhibitor treatment 
(top right) and no-treatment control (top left).  The mean number of organoids larger than 0.2 
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mm in diameter in the microscopic field on day 6 of culture (bottom) (mean  s.d.).  Asterisks, 
P < 0.05. 
 
Figure 6. Wnt promotion by bacterial infection and TNF-.  (A) Relative mRNA levels of 
Wnt-target genes, CD44 and EphB3, in the wild-type mouse stomach (WT), and SPF-Gan 
(SPF), GF-Gan (GF), H. felis-infected GF-Gan (GF->HF), and EP4 inhibitor-treated-Gan 
(EP4i) mouse gastric tumors (mean  s.d).  Asterisks, P < 0.05 versus wild-type level.  (B) 
Immunostaining of CD44 (top) and EphB3 (bottom) in the wild-type mouse stomach (left) and 
SPF-Gan (center) and GF-Gan (right) mouse tumors.  Arrowheads indicate immunostained 
epithelial cells in the wild-type (WT) and GF-Gan mice.  Scale bars, 100m.  (C) 
Immunoblotting of active -catenin in the SPF-K19-Wnt1 and GF-K19-Wnt1 mouse stomach 
(top), and SPF-Gan and GF-Gan mouse gastric tumors (bottom).  -Actin was used as an 
internal control.  (D) The number of preneoplastic lesions developed in SPF-K19-Wnt1 (SPF) 
and GF-K19-Wnt1 (GF) mice.  The mean numbers are indicated.  (E) The mRNA levels of 
TNF- and EphB3 in the gastric tumors of the anti-TNF- neutralizing antibody-treated Gan 
(TNF-) relative to those of untreated control Gan mice (control) (mean  s.d.).  Asterisks, P 
< 0.05 versus control.  (F) Immunoblotting of active -catenin in control (cont) and 
anti-TNF- antibody-treated (TNF-) Gan mouse tumors. 
